Bausch & Lomb Opts Not To Negotiate With Visx For Technolas Eye Laser
This article was originally published in The Gray Sheet
Executive Summary
Bausch and Lomb has no plans to negotiate a patent licensing agreement with laser vision correction market leader Visx prior to introducing the Technolas 217 ophthalmic excimer laser in the U.S., company officials reported at a Feb. 24 teleconference announcing FDA approval.